12
3 Page 3 of 17
45...17
Therapeutic inertia is the failure to advance or deintensify the treatment regimen when a patient’s therapeutic goals are not met. Earlier achievement of glycemic control is critical for improving outcomes for patients with diabetes. There are simple things you can do right now to more rapidly optimize treatment and to remove barriers to care plan adherence – both essential to busting therapeutic inertia. The ADA's Overcoming Therapeutic Inertia (OTI) CE Certificate program is designed to empower clinicians caring for people with diabetes with knowledge and strategies to be a barrier buster.
Member: $125.00
Non-Member: $125.00
11.75 AAPA Category 1 CME credit
During this module, Dr. Kevin Pantalone, Director of Diabetes Initiatives at Cleveland Clinic, and Dr. Chhavi Mehta, Associate Medical Director of Quality at Sutter Diabetes Clinical Improvement Community, will provide practical strategies and tips to help you identify and engage patients in your practice who may be experiencing, or be at risk of experiencing therapeutic inertia. The presenters will discuss options for using various electronic health record platforms as well as low tech approaches. Discussion about leveraging technology to improve the quality and frequency of patient engagement will also be included.
Member: $15.00
Non-Member: $15.00
1.00 AAPA Category 1 CME credit
During this module our presenters will discuss evidence supporting the value of timely therapy optimization to achieving glycemic targets and the legacy effect in type 2 diabetes. This discussion will focus on integrating the ADA type 2 diabetes medication algorithm with effective intensification and deintensification guidance for reducing therapeutic inertia. In order to encourage collaborative decision making between patients, team members, and primary care providers, presenters will provide practical techniques for how and when to use new tools and technology. These include CGM, time in range, and updated medication delivery systems.
Member: $15.00
Non-Member: $15.00
1.00 AAPA Category 1 CME credit
A high-quality and personalized diabetes care plan is an essential tool in overcoming therapeutic inertia in diabetes care. During this practical module, Sandra Leal, PharmD, MPH, FAPhA, CDCES and Nay Linn Aung, MD, will provide an overview of the essential factors to consider when creating a diabetes care plan and will provide you with a template you can use at your office. At the end of this module, you will have increased confidence in your ability to create a truly personalized diabetes care plan that both supports a patient's needs and helps get glucose to target as quickly as possible.
Member: $15.00
Non-Member: $15.00
1.00 AAPA Category 1 CME credit
This module will explore the impact of psychosocial factors on a person with type 2 diabetes achieving glycemic targets and outcomes through day-to-day self-management. Focus will be on tools and techniques for assessing attitudes, beliefs, and expectations for medical management and outcomes in persons with type 2 diabetes. Resources for assessing diabetes distress, depression, and anxiety, along with tips for integrating support mechanisms into the diabetes care team workflow will be covered.
Member: $15.00
Non-Member: $15.00
0.75 AAPA Category 1 CME credit
Lack of time is often cited as the single biggest barrier to optimal diabetes care and a significant contributor to therapeutic inertia. So, how do you prioritize underlying diabetes, helping each diabetes patient quickly achieve and maintain their A1C target while still addressing emergent and co-existing medical challenges? During this webinar, the presenters will discuss simple strategies you can implement right now to modify your workflow and leverage your entire practice as "The Diabetes Intervention”. First, the presenters will walk through a typical patient engagement and workflow process, from pre-visit communication to post-visit follow up. They will then discuss practical and innovative ways to modify your processes, enlist your entire care team, and leverage technology to streamline care and proactively address critical barriers to care plan adherence. Specific recommendations for structuring an effective “diabetes only” visit will also be included.
Member: $15.00
Non-Member: $15.00
1.00 AAPA Category 1 CME credit
Therapeutic inertia in diabetes care is a multifactorial problem. While rapid-cycle therapy optimization is an important piece of achieving timely glucose control, it is simply not enough. Addressing patient-level barrieTherapeutic inertia in diabetes care is a multifactorial problem. While rapid-cycle therapy optimization is an important piece of achieving timely glucose control, it is simply not enough. Addressing patient-level barriers to self-care and follow-through on treatment plan recommendations is critical. To help you engage your team and community as an inertia buster, ADA is hosting this practical online training. During the module we will explore the importance of assessing barriers like social determinants of health, depression, diabetes distress, and health literacy. We will discuss how to consider identified barriers during treatment plan creation. We will also provide suggestions for assessment tools you can use and effective solutions for addressing patient needs and barriers, both in the clinic and through connection with critical community resources, and diabetes self-management education and support (DSMES).
Member: $15.00
Non-Member: $15.00
0.75 AAPA Category 1 CME credit
Therapeutic inertia is responsible for substantial, preventable complications in type 2 diabetes with associated excess in direct and indirect health care costs. During this practical training, we will take an in-depth look at a single patient journey over more than 20 years, exploring best practice approaches to optimize diabetes care, reduce complications, and minimize therapeutic inertia.
Member: $15.00
Non-Member: $15.00
0.75 AAPA Category 1 CME credit
This Self-Assessment Program will test your ability to identify barriers contributing to therapeutic inertia and approaches and tools that reduce therapeutic inertia in clinical scenarios. This program will draw on information, research, and strategies covered in the Overcoming Therapeutic Inertia CE Certificate Program.
Member: $15.00
Non-Member: $15.00
2.50 AAPA Category 1 Self-Assessment CME credit
This recorded webinar provides updates to the 2022 Standards of Medical Care in Diabetes guidelines from Robert A. Gabbay, MD, PhD, Chief Scientific Officer and Medical Officer of the American Diabetes Association. It covers ADA’s current clinical practice recommendations and the standards of care for the management of diabetes and its comorbidities.
Member: $0.00
Non-Member: $0.00
1.00 AAPA Category 1 CME credit
12
3 Page 3 of 17
45...17